Methods and compositions for treatment of cancer with Anti-human nectin-4 therapeutics
TW202626732APending Publication Date: 2026-07-01MERCK SHARP & DOHME CORP +1
0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145618
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-11-21
- Publication Date
- 2026-07-01
Abstract
The present disclosure provides methods, compositions, uses, and kits for treatment of solid cancer (e.g., urothelial cancer (UC), head and neck squamous cell carcinoma (HNSCC), cervical cancer (CC), endometrial carcinoma (EC), or triple-negative breast cancer (TNBC)) using anti-human Nectin-4 therapeutics.
Need to check novelty before this filing date? Find Prior Art